GMP Violations At GSK's Former Puerto Rico Plant Are Basis Of $750 Million DoJ Settlement
In the first False Claims Act case alleging cGMP violations the government cites microbial contamination, split tablets and product mix-ups.
In the first False Claims Act case alleging cGMP violations the government cites microbial contamination, split tablets and product mix-ups.